Trump Administration Approves Massive Bomb Sale to Israel

The Trump administration is moving forward with a significant arms deal to sell tens of thousands of heavy bombs to Israel, valued at approximately $2.8 billion. The package includes 40,000 bombs, comprising 20,000 MK-84 bombs and 20,000 BLU-117 bombs, with some designed for penetrating fortified structures. This sale, which is being funded by U.S. taxpayers, represents the largest single sale of heavy munitions to Israel in recent history, surpassing deals made under both the Biden and previous Trump administrations.

The deal has been sent to Congress for approval, creating a political challenge for Democrats ahead of the November midterm elections. The sale comes amid heightened political tensions in the U.S. regarding military aid to Israel and strained relations between the Biden administration and Prime Minister Benjamin Netanyahu. Over 100 Democratic members of Congress previously voted against continued aid to Israel in July, and some conservative commentators have also questioned the necessity of the annual $3.8 billion aid package.

The U.S. government is reportedly pressuring the chairs of the Senate and House Foreign Affairs committees to ensure the sale's approval. This transaction proceeds despite past U.S. criticism of Israel's use of heavy bombs in populated areas like Gaza and Lebanon, which has drawn international scrutiny. The Biden administration had temporarily halted shipments of heavy bombs in the spring of 2024, but President Trump is expected to reverse this suspension upon taking office in January 2025.

A senior administration official declined to comment on humanitarian concerns, stating only that "all foreign military sales proceed through the appropriate process. We do not comment on pending deals."